Interesting facts
Interesting Facts about 5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
This compound, a member of the benzodiazepine class, exhibits fascinating characteristics that make it significant in various chemistry and pharmacological studies. Here are some key points:
- Benzodiazepine Backbone: The structure of this compound is based on the well-known benzodiazepine framework, which is defined by a fusion of a benzene ring and a diazepine ring. This combination results in a rich chemistry that leads to various therapeutic applications.
- Substituents Matter: The presence of the chlorophenyl and nitro groups in its structure enhances its biological activity, influencing properties such as receptor binding and overall pharmacodynamics.
- Applications: Many benzodiazepines are used for their anxiolytic (anxiety-reducing), sedative, and anticonvulsant effects. While the specific applications of this compound may be under investigation, compounds in its class are frequently involved in the development of new therapies.
- Research Potential: The modification of benzodiazepine structures to create derivatives like this compound opens pathways for drug discovery, allowing scientists to optimize aspects such as potency, selectivity, and safety.
- Synthetic Pathways: The synthesis of such complex compounds often involves multi-step organic reactions, potentially including reactions like nucleophilic substitution and the use of protecting groups, making it a valuable learning experience for chemistry students.
In conclusion, 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one stands at the intersection of medicinal chemistry and organic synthesis, emphasizing the importance of structure-activity relationships in drug development. Its intriguing modifications and applications provide a fertile field for both academic research and practical medicine.
Synonyms
clonazepam
1622-61-3
Klonopin
Chlonazepam
Rivotril
Cloazepam
Iktorivil
Antelepsin
Clonazepamum
Clonopin
Landsen
Lonazep
Antilepsin
Ravotril
Rivatril
Clonex
Kenoket
Paxam
Lktorivil
Solfidin
Alti-Clonazepam
Melzap
Ro 4-8180
Ro 5-4023
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
Klonopin Rapidly Disintegrating
Apetryl
Clonazepam civ
2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-
Clonazepamum [INN-Latin]
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
NSC 179913
Ro-5-4023
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
HSDB 3265
UNII-5PE9FDE8GB
5PE9FDE8GB
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
EINECS 216-596-2
Ro-54023
NSC-179913
BRN 0759557
CHEBI:3756
2H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
CHEMBL452
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
DTXSID1022845
NIOSH/DF2374250
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
NSC179913
Clonazepam [USAN:USP:INN:BAN:JAN]
DF23742500
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
2-H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
Clonazepamum (INN-Latin)
CLONAZEPAM (MART.)
CLONAZEPAM [MART.]
106955-87-7
CLONAZEPAM CIV (USP-RS)
CLONAZEPAM CIV [USP-RS]
CLONAZEPAM (EP MONOGRAPH)
CLONAZEPAM [EP MONOGRAPH]
CLONAZEPAM (USP MONOGRAPH)
CLONAZEPAM [USP MONOGRAPH]
5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
3H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(o-chlorophenyl)-7-nitro-
Clonazepam (1.0 mg/mL in Methanol)
Clonazepam (USAN:USP:INN:BAN:JAN)
Clonazepam (1.0mg/ml in Acetonitrile)
Klonopin (TN)
Ro 54023
Ro 5-4023/B-7
5-(2-chlorophenyl)-7-nitro-1H-benzo(e)(1,4)diazepin-2(3H)-one
DEA No. 2737
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo(e)(1,4)diazepin-2-one
Clonazepam, powder
Ro 4023
RO4023
CLONAZEPAM [MI]
CLONAZEPAM [INN]
CLONAZEPAM [JAN]
CLONAZEPAM [HSDB]
CLONAZEPAM [USAN]
1,4.benzodiazepin-2-one
CLONAZEPAM [VANDF]
CLONAZEPAM [WHO-DD]
BIDD:PXR0144
Oprea1_168772
SCHEMBL38899
MLS003899214
DivK1c_000973
Clonazepam (JP18/USP/INN)
DTXCID002845
GTPL6963
Clonazepam, 1mg/ml in Methanol
CLONAZEPAM [ORANGE BOOK]
HMS503C07
KBio1_000973
N03AE01
NINDS_000973
HMS2093H22
Clonazepam 0.1 mg/ml in Methanol
Clonazepam 1.0 mg/ml in Methanol
VGA08215
BDBM50019213
AKOS015902192
CCG-213669
DB01068
IDI1_000973
WLN: T67 GMV JN IHJ CNW KR BG
AC-15733
SMR000058982
SBI-0206863.P001
NS00010427
5-(2-Chlorophenyl)-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,4-benzodiazepin-2-one
D00280
AB01563349_01
A810362
Q407988
SR-01000937610
2-H-1, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
2H-1, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-
2H-1, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
Q-200880
SR-01000937610-2
BRD-K38183498-001-02-0
Clonazepam, European Pharmacopoeia (EP) Reference Standard
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one #
5-(2-chlorophenyl)-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-nitro-1,3-dihydro-5-(o-chlorophenyl)-2H-1,4-benzodiazepin-2-one
216-596-2
Solubility of 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one (C15H10ClN3O3)
The solubility of the compound 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one exhibits noteworthy characteristics influenced by its molecular structure.
Key Solubility Characteristics:
In conclusion, understanding the solubility of C15H10ClN3O3 requires a comprehensive investigation featuring various solvents, temperatures, and pH levels to fully elucidate its behavior in different environments. The distinctive features embedded in its structure play a pivotal role in determining how this compound interacts within those parameters.